Medpace Holdings Inc (MEDP)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
August J. Troendle
Employees:
4,500
5375 MEDPACE WAY, CINCINNATI, OH 45227
(513) 579-9911

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company was founded in 1992 and is based in Cincinnati, Ohio.

Data derived from most recent annual or quarterly report
Market Cap 5.825 Billion Shares Outstanding35.23 Million Avg 30-day Volume 477.154 Thousand
P/E Ratio24.0976 Dividend Yield0.0 EPS2.32
Price to Revenue3.9207 Debt to Equity0.8815 EBITDA259.346 Million
Price to Book Value17.8044 Operating Margin18.1149 Enterprise Value5.25 Billion
Current Ratio0.374 EPS Growth0.241 Quick Ratio0.305
1 Yr BETA 1.2919 52-week High/Low 231.0 / 126.95 Profit Margin16.2702
Operating Cash Flow Growth0.2737 Altman Z-Score3.5311 Free Cash Flow to Firm 227.378 Million
Earnings Report2022-10-24
View SEC Filings from MEDP instead.

View recent insider trading info

Funds Holding MEDP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MEDP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-07-25:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-10:
    Item 8.01: Other Events
  • 8-K: filed on 2022-05-26:
    Item 8.01: Other Events
  • 8-K: filed on 2022-05-20:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-04-25:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-25:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    1.9 Million total shares from 30 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MEDPACE INVESTORS, LLC

    • 10% Owner
    6,483,019 2022-09-22 23

    TROENDLE AUGUST J. CEO

    • Officer
    • Director
    • 10% Owner
    7,289,662 2022-09-22 25

    DAVENPORT FRED B JR

    • Director
    3,903 2022-05-20 2

    KRAFT ROBERT O.

    • Director
    1,903 2022-05-20 1

    CARLEY BRIAN T

    • Director
    1,903 2022-05-20 1

    MCCARTHY CORNELIUS P. III

    • Director
    1,903 2022-05-20 1

    KEATING ASHLEY M.

    • Director
    1,903 2022-05-20 2

    KING TOM C

    • Director
    2,501 2022-05-20 2

    EWALD STEPHEN P GENERAL COUNSEL & CORP. SECY.

    • Officer
    21,354 2022-05-06 3

    BURWIG SUSAN E EXEC. VP, OPERATIONS

    • Officer
    20,183 2022-02-23 2

    GEIGER JESSE J PRESIDENT

    • Officer
    38,089 2022-02-15 2

    BRADY KEVIN M. CFO & TREASURER

    • Officer
    18,803 2022-02-15 2

    BROWN BRUCE

    • Director
    9,295 2019-05-17 0

    MEDPACE LIMITED PARTNERSHIP

    MEDPACE GP LTD

    CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD

    CINVEN CAPITAL MANAGEMENT (V) LIMITED PARTNERSHIP INC

    • 10% Owner
    No longer subject to file 2018-08-27 0

    FIFTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 3) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 5) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 6) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

    CINVEN MANCO S.A.R.L.

    FIFTH CINVEN FUND FCP-SIF

    • 10% Owner
    No longer subject to file 2017-06-21 0

    MEDPACE LIMITED PARTNERSHIP

    MEDPACE GP LTD

    • 10% Owner
    22,999,997 2017-06-21 0

    BUCKNELL PENELOPE J VP, HUMAN RESOURCES

    • Officer
    3,000 2017-05-02 0

    FIFTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 3) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 5) LIMITED PARTNERSHIP

    FIFTH CINVEN FUND (NO. 6) LIMITED PARTNERSHIP

    • 10% Owner
    22,999,997 2016-08-10 0

    CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD

    CINVEN CAPITAL MANAGEMENT (V) LIMITED PARTNERSHIP INC

    CINVEN MANCO S.A.R.L.

    FIFTH CINVEN FUND FCP-SIF

    FIFTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

    • 10% Owner
    22,999,997 2016-08-10 0

    NORTON MATTHEW RICHARD

    • Director
    0 2016-08-10 0

    LESLIE ALEXANDER F S

    • Director
    0 2016-08-10 0

    RAJAGOPALAN SUPRAJ R

    • Director
    0 2016-08-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-23 16:01:54 -0400 2022-09-22 P 57,426 $154.59 a 6,483,019 indirect yes 0.5551 8.862 8.862 6 0.0 1

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-23 16:02:33 -0400 2022-09-22 P 57,426 $154.59 a 6,483,019 direct yes 0.5551 8.862 8.862 6 0.0 1

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-22 16:13:21 -0400 2022-09-21 P 94,119 $161.63 a 6,425,593 direct yes 1.6027 8.1098 8.1098 6 0.0 1

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-22 16:13:58 -0400 2022-09-21 P 94,119 $161.63 a 6,425,593 indirect yes 1.6027 8.1098 8.1098 6 0.0 1

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-22 16:13:21 -0400 2022-09-20 P 94,119 $155.14 a 6,331,474 direct yes 1.6027 8.1098 8.1098 6 0.0 1

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-22 16:13:58 -0400 2022-09-20 P 94,119 $155.14 a 6,331,474 indirect yes 1.6027 8.1098 8.1098 6 0.0 1

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-20 16:10:18 -0400 2022-09-19 P 94,119 $153.48 a 6,237,355 indirect yes -0.6098 0.4044 0.4044 6 -6.6761 3

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-20 16:11:18 -0400 2022-09-19 P 94,119 $153.48 a 6,237,355 direct yes -0.6098 0.4044 0.4044 6 -6.6761 3

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-20 16:10:18 -0400 2022-09-16 P 62,516 $149.58 a 6,143,236 indirect yes -0.6098 0.4044 0.4044 6 -6.6761 3

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-20 16:11:18 -0400 2022-09-16 P 62,516 $149.58 a 6,143,236 direct yes -0.6098 0.4044 0.4044 6 -6.6761 3

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-16 16:09:22 -0400 2022-09-15 P 62,516 $153.11 a 6,080,720 direct yes 0.3546 -4.7769 0.4255 3 -6.279 5

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-16 16:09:57 -0400 2022-09-15 P 62,516 $153.11 a 6,080,720 indirect yes 0.3546 -4.7769 0.4255 3 -6.279 5

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-16 16:09:22 -0400 2022-09-14 P 62,516 $152.66 a 6,018,204 direct yes 0.3546 -4.7769 0.4255 3 -6.279 5

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-16 16:09:57 -0400 2022-09-14 P 62,516 $152.66 a 6,018,204 indirect yes 0.3546 -4.7769 0.4255 3 -6.279 5

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-14 16:15:41 -0400 2022-09-13 P 62,516 $157.12 a 5,955,688 direct yes -0.3961 2.2183 2.8454 5 -0.3961 2

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-14 16:16:42 -0400 2022-09-13 P 62,516 $157.12 a 5,955,688 indirect yes -0.3961 2.2183 2.8454 5 -0.3961 2

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-14 16:15:41 -0400 2022-09-12 P 62,515 $167.58 a 5,893,172 direct yes -0.3961 2.2183 2.8454 5 -0.3961 2

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-14 16:16:42 -0400 2022-09-12 P 62,515 $167.58 a 5,893,172 indirect yes -0.3961 2.2183 2.8454 5 -0.3961 2

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-12 16:14:18 -0400 2022-09-09 P 56,557 $164.33 a 5,830,657 direct yes -2.2106 1.8116 1.8116 6 -2.2106 2

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-12 16:15:10 -0400 2022-09-09 P 56,557 $164.33 a 5,830,657 indirect yes -2.2106 1.8116 1.8116 6 -2.2106 2

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-12 16:14:18 -0400 2022-09-08 P 56,557 $157.65 a 5,774,100 direct yes -2.2106 1.8116 1.8116 6 -2.2106 2

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-12 16:15:10 -0400 2022-09-08 P 56,557 $157.65 a 5,774,100 indirect yes -2.2106 1.8116 1.8116 6 -2.2106 2

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-08 16:11:22 -0400 2022-09-07 P 56,557 $150.72 a 5,717,543 direct yes 3.0903 -7.4928 3.0903 2 -8.3206 4

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-08 16:10:37 -0400 2022-09-07 P 56,557 $150.72 a 5,717,543 indirect yes 3.0903 -7.4928 3.0903 2 -8.3206 4

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-08 16:11:22 -0400 2022-09-06 P 56,557 $147.59 a 5,660,986 direct yes 3.0903 -7.4928 3.0903 2 -8.3206 4

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-08 16:10:37 -0400 2022-09-06 P 56,557 $147.59 a 5,660,986 indirect yes 3.0903 -7.4928 3.0903 2 -8.3206 4

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-06 16:17:13 -0400 2022-09-02 P 48,714 $144.98 a 5,604,429 indirect yes 2.9738 -2.4912 9.6452 4 -2.4912 6

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-06 16:18:07 -0400 2022-09-02 P 48,714 $144.98 a 5,604,429 direct yes 2.9738 -2.4912 9.6452 4 -2.4912 6

    MEDPACE INVESTORS, LLC - > 10% Owner

    2022-09-06 16:18:07 -0400 2022-09-01 P 42,076 $144.52 a 5,555,715 direct yes 2.9738 -2.4912 9.6452 4 -2.4912 6

    TROENDLE AUGUST J. - Director - Officer - > 10% Owner CEO by medpace investors, llc

    2022-09-06 16:17:13 -0400 2022-09-01 P 42,076 $144.52 a 5,555,715 indirect yes 2.9738 -2.4912 9.6452 4 -2.4912 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MEDPACE HOLDINGS INC MEDP 2022-10-05 22:15:03 UTC 2.7935 0.2765 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 21:45:03 UTC 2.7938 0.2762 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 21:15:04 UTC 2.7938 0.2762 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 20:45:03 UTC 2.7973 0.2727 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 20:15:04 UTC 2.7973 0.2727 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 19:45:04 UTC 2.7973 0.2727 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 19:15:04 UTC 2.7973 0.2727 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 18:45:03 UTC 2.7974 0.2726 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 18:15:03 UTC 2.7974 0.2726 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 17:45:03 UTC 2.7974 0.2726 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 17:15:03 UTC 2.7974 0.2726 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 16:45:04 UTC 2.7958 0.2742 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 16:15:03 UTC 2.7958 0.2742 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 15:45:03 UTC 2.7958 0.2742 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 15:15:03 UTC 2.7958 0.2742 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 14:45:03 UTC 2.7958 0.2742 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 14:15:03 UTC 2.7958 0.2742 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 13:45:03 UTC 2.8176 0.2524 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 13:15:03 UTC 2.8176 0.2524 750000
    MEDPACE HOLDINGS INC MEDP 2022-10-05 12:45:03 UTC 2.8176 0.2524 750000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    NORTHERN LIGHTS FUND TRUST II- Invenomic Fund MEDP -60929.0 shares, $-10329293.37 2022-07-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    representative Josh Gottheimer democrat House Filing 2022-08-04 2022-07-22 SP $1,001-$15,000

    Elevate your investments